Events

The Food and Drug Administration (FDA, the Agency, or we) is hosting a virtual public meeting entitled “Potential Approach for Ranking of Antimicrobial Drugs According to Their Importance in Human Medicine: A Risk Management Tool for Antimicrobial New Animal Drugs.” The purpose of the meeting is to obtain early input from the public on a […]

Join us Tuesday, November 17, at 10 AM – 11 AM ET for an update on CARB-X, and an insider’s look at 3 innovative programs supported by CARB-X CARB-X is hosting this special webinar to showcase some of the exciting science in the CARB-X portfolio and the progress CARB-X is making supporting the development of […]

Speakers: James J. Collins, Termeer Professor of Medical Engineering & Science Professor, Broad Institute of MIT and Harvard (USA) Cesar de la Fuente, Presidential Assistant Professor, University of Pennsylvania (USA) Henriette Willems, Senior Research Associate, The ALBORADA Drug Discovery Institute, University of Cambridge, (UK) Fredrik Svensson, Senior Research Associate, UCL Drug Discovery Institute, London, (UK) […]

The theme for World Antimicrobial Awareness Week 2020 for the human health sector is “United to preserve antimicrobials.” Every year, World Antimicrobial Awareness Week aims to increase awareness of global antimicrobial resistance (AMR) and to encourage best practices among the general public, health workers and policy makers to stop the further emergence and spread of […]

CARB-X participants include Nadia Cohen, Alliance Manager, who will present during the Accelerating AMR R&D section of the program at 10:40 EST, and Betsy Wonderly Trainor, Alliance Director, who will present at 10:20 EST. Learn about the latest AMR technologies in a series of interactive key note lectures by international Captains of Industry and Leading […]

Over the last year, Wellcome has mapped the global response to AMR to identify progress made since the UN High-Level Meeting on AMR held in 2016.  The analysis captures the views of over 150 experts and reviewed more than 250 documents and aims to bring all this together in a critical path for what the […]

AMR in the Light of COVID-19 - A Webinar Series Each of us is now living in a world with a nearly untreatable virus - but COVID-19 is not the only threat that we are facing. Many bacterial and fungal infections that were previously considered treatable are no longer responding to the drugs designed to […]

Speakers: Prof Hanan Balkhy, Assistant Director-General for Antimicrobial resistance, WHO Dr Manica Balasegaram, Executive Director, GARDP - Dr Dhanya Dharmapalan, paediatrician and member of the Pediatric Infectious Disease Society (PIDS), Mumbai Dr Borna Nyaoke, Senior Clinical Project Manager, DNDi/GARDP Kenya Moderator: Dr Peter Beyer, Senior Advisor, AMR Division, WHO The presentations will be followed by […]

In December 2019 SARS-CoV-2 the cause of COVID-19, was responsible for thousands of deaths in Wuhan, China. By March 11, 2020, WHO declared COVID-19 as a worldwide pandemic.The single most effective way to tackle this pandemic is a working vaccine, which is why Vaccine Congress West Coast is bringing together experts who have been working […]

Translating AMR R&D mapping into policy and action. The Global AMR R&D Hub, through its Dynamic Dashboard, is the global knowledge centre for AMR R&D. The Dynamic Dashboard captures and presents: AMR R&D investments from across the globe and One Health sectors; what new antibacterials are in the pipeline; and what is being done to […]